Innovize and Excel Scientific Join Forces Through Acquisition
Recently, Vance Street Capital, a private equity firm based in Los Angeles, made an exciting announcement about the acquisition of Zenith Adhesive Components (ZAC) by its portfolio companies, Innovize and Excel Scientific. This strategic move reflects their commitment to expanding expertise and enhancing capacity in the medical and life science sectors.
Founded in 2012, Zenith Adhesive Components is recognized for its strong partnerships centered on reliability and innovation. The company has established itself as a reputable contract manufacturer, providing technically sophisticated solutions that meet the evolving needs of the medical, life science, and high-technology markets. With this acquisition, Innovize and Excel Scientific aim to elevate their offerings and better serve their global clientele.
John LeRosen, a partner at Vance Street Capital, expressed his enthusiasm about bringing together these esteemed brands. He stated, "Each brand offers unique and proprietary capabilities that, when combined, will significantly bolster the entire platform, enhancing our service capabilities across multiple regions." This brings forth a collaborative spirit aimed at addressing customer needs efficiently.
Julie Cameron, the CEO of Innovize and Excel Scientific, echoed this sentiment, stating, "We found the perfect partner in Zenith, aligning with our focus on customer satisfaction and innovative solutions. Their team possesses invaluable expertise that will enhance our service offerings significantly." The collaboration strategically positions them to cater to demand not only in North America but also in European markets.
Pat O'Neill, founder of ZAC, couldn't hide his excitement regarding the acquisition. He shared, "The Zenith Adhesive Components team is eager to embark on this new journey. Our location and expertise complement Innovize and Excel Scientific’s impressive portfolio of high-quality medical products. This partnership marks a significant leap forward in meeting future industry requirements, benefitting our stakeholders substantially."
According to Grady Miller, Principal at Vance Street Capital, the combination of these three companies will enhance their existing infrastructures and allow for a more comprehensive support system for clients domestically and internationally. He noted that this union would facilitate increased market reach across the life sciences and medical sectors, ultimately creating value for all parties involved.
Innovize, established in 1958, has long been a leader in contract medical manufacturing, specializing in adhesive and film-based solutions. The firm caters to various sectors including diabetes, cardiac, neurological, surgical, and diagnostic fields. With its acquisition of Excel Scientific in 2022, Innovize has broadened its scope, further solidifying its stance in the healthcare sector.
Excel Scientific, founded in 1992 and headquartered in Victorville, California, is known for its innovative microplate sealing films and foils, which are vital for life science research and various laboratory applications. Its acquisition by Vance Street Capital in 2020 was aimed at pursuing strategic initiatives for growth and market expansion.
About Vance Street Capital LLC
Vance Street Capital focuses on the middle-market segment, investing in businesses that provide highly engineered solutions across diverse industries such as industrial technology, medical, life sciences, aerospace, and defense. They partner with management teams and family-owned businesses to facilitate revenue growth and operational improvements, ensuring the long-term success of the entities they invest in.
To learn more about their initiatives and portfolio, visit www.vancestreetcapital.com.
For media inquiries, please contact:
Natalie Yates
Head of Business Development and Investor Relations
